Date published: 2026-5-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

AF-10 Inhibitors

AF-10 inhibitors represents a specialized group of organic compounds characterized by their distinctive molecular structures and their ability to interact with specific components of the AF-10 gene or its associated proteins. These inhibitors are the product of meticulous research and experimentation aimed at elucidating the intricate biochemical pathways involving AF-10, a gene intricately linked to hematopoiesis and cellular regulation. The design and development of AF-10 inhibitors are rooted in a profound understanding of the gene's role in cellular processes and its potential contributions to various physiological mechanisms. AF-10 inhibitors display a remarkable diversity in their chemical compositions, which is reflective of the multifaceted nature of AF-10 and its complex interactions within cellular pathways. Researchers employ cutting-edge techniques to engineer these inhibitors, tailoring their structural features to selectively bind to specific regions of AF-10 or its binding partners. This precise molecular targeting allows AF-10 inhibitors to interfere with the intricate interactions that govern AF-10's function, providing an invaluable tool for probing the gene's role in cellular biology. The development of AF-10 inhibitors involves a meticulous process of rational design and empirical testing, guided by insights gained from structural biology, computational modeling, and detailed biochemical analysis. By systematically probing the interactions between AF-10 and its associated molecules, researchers aim to uncover the fundamental mechanisms that underlie AF-10's involvement in cellular processes. This line of inquiry has led to the discovery of a diverse array of AF-10 inhibitors, each with its own unique chemical signature and binding profile. AF-10 inhibitors hold significant promise as powerful instruments for scientific investigation, enabling researchers to dissect the complex web of molecular events that involve AF-10.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-β-D-ribofuranosyl]-9H-purin-6-amine

1380288-87-8sc-500607
50 mg
$13500.00
(0)

This small molecule inhibitor targets the DOT1L enzyme, which is involved in the regulation of AF-It has been investigated for its potential in MLL-rearranged leukemia.

Epz004777

1338466-77-5sc-507560
100 mg
$575.00
(0)

This compound targets the AF10-BRD9 interaction and has been investigated for its anti-leukemic effects.

GSK J1

1373422-53-7sc-391113
sc-391113A
10 mg
50 mg
$193.00
$813.00
(0)

Although primarily known as a histone demethylase inhibitor, GSK-J1 has been studied for its impact on MLL-AF10 leukemia.

UNC1999

1431612-23-5sc-475314
5 mg
$142.00
1
(0)

This compound is a potent inhibitor of the menin-MLL interaction, which is relevant in MLL-fusion leukemias.